Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]
Phase 3 trial assessing efficacy and safety of mepolizumab in frequently exacerbating COPD; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Effects of Two Training Protocols in Patients With Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial evaluating two training protocols in patients with chronic obstructive pulmonary disease. The study status is rep…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) [Phase 2]
Phase 2 clinical trial (APPLE-COPD: ICON 2) evaluating antiplatelet therapy to prevent cardiovascular disease in patients with COPD; study s…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of indacaterol maleate/glycopyrronium bromide in chronic obstructive pulmonary disease; the…
-
FDA approval · 2018-04-02FDA Approved: STRIVERDI RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for STRIVERDI RESPIMAT (olodaterol) from Boehringer Ingelheim Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: An Intervention to Improve Function in Severe Cardiopulmonary Illness [NA]
This document reports a completed clinical trial testing an intervention intended to improve function in people with severe cardiopulmonary …
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251 [Phase 2]
Phase 2 clinical trial on QBW251 in COPD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD [Phase 1]
A Phase 1 trial evaluated the acute bronchodilator effects of inhaled albuterol sulfate and ipratropium bromide in patients with stable chro…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Evaluation of COPD Co-Pilot
This clinical trial update concerns evaluating COPD Co-Pilot, sponsored by HGE Health Care Solutions. The current status of the trial is unk…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Breath Analysis in Chronic Obstructive Lung Disease (COPD)
A completed clinical trial from the University of Zurich investigating breath analysis in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Combination of NHF and Nebulizer on Lung Function in COPD [NA]
Clinical trial update indicates a completed study assessing the combination of nasal high-flow therapy (NHF) and a nebulizer on lung functio…
-
FDA approval · 2018-03-23FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients [NA]
A completed clinical trial evaluated the effects of oxygen supplementation during exercise in patients with chronic obstructive pulmonary di…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD [Phase 3]
Phase 3 trial evaluating the efficacy and safety of 12 weeks of nebulized SUN-101 in patients with chronic obstructive pulmonary disease; re…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Program Evaluation of Telehomecare: TeLeCare Study
Clinical trial update on the TeLeCare telehomecare program evaluating management of heart failure and chronic obstructive pulmonary disease;…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging [Phase 2]
Phase 2 trial evaluating roflumilast in hyperinflated COPD patients using functional respiratory imaging has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. [Phase 4]
Phase 4 clinical trial update reporting bone mineral density results in patients with chronic obstructive pulmonary disease treated with the…
-
CLINICAL_TRIALS research · 2018-03-16Clinical Trial Update: Multicenter Study of Impulse Oscillometry in Chinese
A multicenter clinical trial update from Guangzhou Institute of Respiratory Disease on impulse oscillometry in Chinese participants, includi…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial evaluating a closed-loop system for oxygen delivery during exercise in patients with chronic obstructive pulmonar…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD [Phase 3]
A Phase 3 long-term safety trial of nebulized SUN-101 in chronic obstructive pulmonary disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) [Phase 3]
A Phase 3 efficacy and safety trial evaluating 12 weeks of nebulized SUN-101 in COPD has completed, with results posted.
-
CLINICAL_TRIALS research · 2018-03-13Clinical Trial Update: Evaluation of COPD Co-Pilot
A clinical trial update concerning COPD Co-Pilot sponsored by HGE Health Care Solutions, with the current trial status shown as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 trial evaluating the safety and ability of once-daily glycopyrrolate inhalation solution delivered via an eFlow nebulizer to impro…
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
This clinical trial update covers the screening evaluation for studies involving Chronic Obstructive Pulmonary Disease (COPD) led by Johns H…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating SUN101 (EP-101) for efficacy and safety in moderate-to-severe chronic obstructive pulmonary disease has completed, …